Innate Neural Stem Cell Heterogeneity Determines the Patterning of Glioma Formation in Children Researchers demonstrated that lateral ventricle subventricular zone neural stem cells (NSCs) are molecularly and functionally distinct from those of the third ventricle. Consistent with a unique origin for pediatric low-grade glioma, third ventricle, but not lateral ventricle, NSCs hyperproliferate in response to mutations characteristic of childhood glioma. [Cancer Cell] Abstract | Press Release
Oligodendroglia Metabolically Support Axons and Contribute to Neurodegeneration Researchers showed that the most abundant lactate transporter in the central nervous system, monocarboxylate transporter 1 is highly enriched within oligodendroglia and that disruption of this transporter produces axon damage and neuron loss in animal and cell culture models. [Nature] Abstract
Sushi Domains Confer Distinct Trafficking Profiles on GABAB Receptors Results suggest a role for Sushi domains in stabilizing cell surface receptors that could impart different pre- and postsynaptic trafficking itineraries on GABAB receptors, thereby contributing to their physiological and pathological roles. [Proc Natl Acad Sci USA] Abstract
Biotie Completes Enrollment in Phase IIb Trial of Tozadenant in Parkinson’s Disease Biotie announced that enrollment is complete in its Phase IIb trial evaluating the safety and efficacy of tozadenant in Parkinson’s disease. Biotie now expects the top-line data from this study to be available at around the end of 2012, whereas previous guidance was H1 2013. [Biotie Therapies Corp.] Press Release
Parkinson’s Vaccine – Worldwide First Clinical Study in Vienna The worldwide first clinical trial for the development of a Parkinson’s vaccine has now been started by AFFiRiS AG. The vaccine called PD01A is directed against alpha-Synuclein, a protein considered to cause the onset and progression of the disease, and is currently being tested on Parkinson’s patients in a Phase I trial. [AFFiRiS AG] Press Release
Death of Evidence Announcement To make the public aware of government cuts to federal science programs, Canadians organized a ‘Death of Evidence’ rally to coincide with a large scientific conference taking place in Ottawa. [Death of Evidence, Canada] Press Release
Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
Have we missed an important article or publication in Neural Cell News? Click here to submit!